PatternsRadar
Sign in

BAJAJHCAREBajaj Healthcare Limited

NSE
320.15INR+1.65 (+0.52%)Close · 20 Nov 2026
17 Oct 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,078 CrMarket cap
52.3P/E (TTM)
52.8%Delivery

Filings & corporate actions

19 results filed
CSV
Next results · Q3 FY27
Expected 16 Jan 2027 – 12 Feb 2027
Estimate: filed 16–43 days after quarter end, last 4 times
Dividend
₹1.50 per share · last 11 Sept 2026
2026
  • 19 OctshareholdingShareholding · 30 Sept 2026-0.8%NSE
  • 17 OctresultsResults · Q2 FY27 · standalone-0.8%NSE
  • 11 SeptdividendDividend · ₹1.50 per share+0.2%
  • 20 JulresultsResults · Q1 FY27 · standalone-4.4%NSE
  • 15 JulshareholdingShareholding · 30 Jun 2026+4.6%NSE
  • 8 MayresultsResults · Q4 FY26 · standalone-9.5%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026-0.6%NSE
  • 25 MarshareholdingShareholding · 18 Mar 2026+2.2%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025+0.2%NSE
  • 16 JanresultsResults · Q3 FY26 · standalone+0.2%NSE

Reaction to results · all yearsrose on day 0 in 5 of 19 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2717 Oct 2026-0.8%-8.9%-5.7%2.4×
Q1 FY2720 Jul 2026-4.4%-16.8%-16.6%0.8×
Q4 FY268 May 2026-9.5%-18.3%-13.2%4.9×
Q3 FY2616 Jan 2026+0.2%-15.0%-8.5%4.8×
Q2 FY2617 Oct 2025-2.1%-3.8%-7.2%0.2×
Q1 FY2628 Jul 2025-2.6%-11.7%-18.3%3.2×
Q4 FY2527 May 2025-0.7%-5.8%-5.4%0.7×
Q3 FY2512 Feb 2025+9.9%+16.6%+7.0%1.0×
Q2 FY2515 Nov 2024-2.6%+2.0%+20.0%1.4×
Q1 FY2514 Aug 2024-3.6%-2.0%-7.6%1.4×
Q4 FY2425 May 2024-2.2%-5.8%+10.7%2.9×
Q3 FY2410 Feb 2024-7.6%-1.1%-2.3%2.4×
Q2 FY2410 Nov 2023-4.8%-0.3%-7.7%1.4×
Q1 FY2414 Aug 2023-1.4%-6.2%+25.1%2.3×
Q4 FY2331 May 2023-0.9%-2.4%+7.4%1.7×
Q2 FY2311 Nov 2022+0.7%+6.8%+16.9%0.7×
Q1 FY2313 Aug 2022+1.4%-4.2%+0.7%1.0×
Q4 FY2218 May 2022+9.2%+2.9%-5.0%8.4×
Q3 FY2228 Jan 2022-1.9%+3.4%-5.4%1.4×
Average-1.2%-3.7%-0.8%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+18.9%
Profit YoY+26.9%
Interest cost YoY+5.1%
Revenue QoQ+6.2%
Profit QoQ+2.9%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+13.6%—-2.2%———
Profit——-24.5%———

Key data

Open315.00
Day range315.00 – 321.45
52-week range272.35 – 458.00
From 52w high-30.1%
RSI (14)50.2
ATR (14)9.94
Volume50.4K
Avg volume (20D)74.2K
Rel volume0.68×
Volatility (1Y)42.1%
Turnover₹1.6Cr
Traded value (NSE)₹1.6Cr
VWAP318.72
SMA 50 / 200324.46 / 325.28
Price band20%

Delivery percentage

Latest · 20 Nov 202652.8%
20-day avg50.2%
1-year avg43.3%
Percentile (own history)70th
Range4.8–85.6%
Sessions1,235

Over the last 20 sessions BAJAJHCARE settled 50.2% of its traded quantity, which is above average for an NSE equity. Its one-year average is 43.3%, so recent sessions are running 7.0 points higher than usual. The latest session ranks higher than 70% of the 1,235 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.47%
Dividend, trailing 12M₹1.50
Paid every year for5 yr
Shareholders40.8K · -1.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy144 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.52%-1.02%-1.39%-1.78%+5.16%-28.42%

Valuation

Market cap₹1,078 Cr
Market cap (NSE)₹1,078 Cr
Free-float cap₹446 Cr
P/E (TTM)52.3
P/E (NSE)52.0
EPS (TTM)6.12
P/B1.9
Net margin (TTM)3.1%
Other income / PBT18.9%
ROE4.0%
Debt / equity0.48
Shares outstanding3.37Cr
Listed25 Nov 2021

Ownership

Promoter58.59%
Promoter Δ QoQ0.00 pp
Public41.41%
FII2.09%
DII1.96%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)161.2153.1165.6175.9
YoY chg+31.3%-0.9%+11.3%+18.9%
Net profit (₹ Cr)15.7(22.9)13.714.1
YoY chg+33.7%-304.4%+15.8%+26.9%
Net margin9.7%-14.9%8.3%8.0%
EPS4.87-7.154.064.18

Shareholding over time

By quarter

30 Sept 2026 · promoter 58.59% · public 41.41%
19 Nov 2021: promoter 67.26%31 Dec 2021: promoter 67.26%31 Mar 2022: promoter 67.26%30 Jun 2022: promoter 67.30%30 Sept 2022: promoter 67.30%31 Dec 2022: promoter 67.42%31 Mar 2023: promoter 67.49%30 Jun 2023: promoter 67.49%30 Sept 2023: promoter 67.69%31 Dec 2023: promoter 67.73%31 Mar 2024: promoter 67.73%30 Jun 2024: promoter 67.73%19 Sept 2024: promoter 59.19%30 Sept 2024: promoter 59.19%31 Dec 2024: promoter 59.19%31 Mar 2025: promoter 59.19%30 Jun 2025: promoter 59.19%30 Sept 2025: promoter 59.19%31 Dec 2025: promoter 59.19%18 Mar 2026: promoter 58.29%31 Mar 2026: promoter 58.29%30 Jun 2026: promoter 58.59%30 Sept 2026: promoter 58.59%
2021-112026-09
  • Promoter
  • Public and others
Promoter
58.59%
Public
41.41%
Promoter change
0.00 pp
Filed
19 Oct 2026
FII
2.09%
DII
1.96%
Promoter pledged
0.00%

Who the public is

Mutual funds
1.69%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
2.09%

-0.10 pp QoQ

Retail ≤ ₹2L
23.88%

+1.25 pp QoQ

HNI > ₹2L
6.92%

-0.27 pp QoQ

NRI
1.47%

+0.06 pp QoQ

Bodies corporate
3.23%

-0.44 pp QoQ

Shareholders
40,754

-1.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
SAJANKUMAR RAMESHWARLAL BAJAJPromoter · Individual36.61%
ANIL CHAMPALAL JAINPromoter · Individual6.05%
NAMRATA BAJAJPromoter · Individual4.85%
NIHITA BAJAJ KUMARPromoter · Individual4.81%
BABITA SAJANKUMAR BAJAJPromoter · Individual4.47%
DEEPAK RAMANLAL JOSHIIndividual2.32%
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUNDMutual fund1.69%
PADMA ANIL JAINPromoter · Individual0.90%
BAJAJ HEALTH AND NUTRITIONS LLPPromoter · Corporate0.71%
BANSAL PHARMA LIMITEDPromoter · Corporate0.18%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 22 Sept 2022 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹1.50₹1.50
FY2025-261₹1.00₹1.00
FY2024-251₹1.00₹1.00
FY2023-241₹1.00₹1.00
FY2022-231₹1.50₹1.50
Ex-dateRecord dateDeclaredAdjusted
11 Sept 2026—₹1.50₹1.50
19 Sept 2025—₹1.00₹1.00
23 Sept 2024—₹1.00₹1.00
22 Sept 2023—₹1.00₹1.00
22 Sept 2022—₹1.50₹1.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
5 months ago
Disclosures on record
20
16 open-market of the newest 20
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
15 Jun 2026ANIL CHAMPALAL JAINPromoterBuy1.00L₹3.0Cr297.3019.37L → 20.37L6.05%+0.30 pp7(2)told 15 Jun 2026
20 Mar 2026ANIL CHAMPALAL JAINPromoterBuy7.1K₹19.9L280.6014.74L → 14.81L4.69%+0.02 pp7(2)told 18 Mar 2026
18 Mar 2026ANIL CHAMPALAL JAINPromoterBuy7.6K₹21.3L280.1214.67L → 14.74L4.67%+0.02 pp7(2)told 17 Mar 2026
18 Mar 2026ANIL CHAMPALAL JAINPromoterBuy3.0K₹8.7L291.5014.64L → 14.67L4.64%+0.01 pp7(2)told 16 Mar 2026
16 Feb 2024Namrata BajajPromoterBuy2.0K₹6.4L321.4416.30L → 16.32L5.91%+0.01 pp7(2)told 15 Feb 2024
16 Nov 2023Anil Champalal JainPromoterBuy10.2K₹39.9L392.2114.52L → 14.62L5.30%+0.04 pp7(2)told 16 Nov 2023
21 Sept 2023Sajankumar Rameshwarlal BajajPromoterBuy56.0K₹2.5Cr445.2196.55L → 97.11L35.19%+0.20 pp7(2)told 21 Sept 2023
29 Mar 2023Namrata Sajankumar BajajPromoterBuy707₹2.0L284.4016.30L → 16.30L5.91%+0.00 pp7(2)told 29 Mar 2023
29 Mar 2023Anil Champalal JainPromoterBuy4.1K₹11.9L289.7514.47L → 14.52L5.26%+0.01 pp7(2)told 29 Mar 2023
29 Mar 2023Sajankumar Rameshwarlal BajajPromoterBuy13.8K₹39.7L288.7796.41L → 96.55L34.98%+0.05 pp7(2)told 29 Mar 2023
16 Dec 2022Anil Champalal JainPromoterBuy5.5K₹24.0L437.0014.42L → 14.47L5.25%+0.02 pp7(2)told 16 Dec 2022
14 Dec 2022Anil Champalal JainPromoterBuy6.0K₹25.8L429.2514.36L → 14.42L5.23%+0.02 pp7(2)told 14 Dec 2022
19 Nov 2022Sajankumar Rameshwarlal BajajPromoterBuy12.9K₹49.9L385.6596.28L → 96.41L34.99%+0.05 pp7(2)told 18 Nov 2022
19 Nov 2022Nihita Bajaj KumarPromoterBuy4.4K₹17.0L390.0416.16L → 16.20L5.87%+0.02 pp7(2)told 19 Nov 2022
19 Nov 2022Namrata Sajankumar BajajPromoterBuy5.0K₹19.3L386.8216.25L → 16.30L5.90%+0.02 pp7(2)told 19 Nov 2022
1 Apr 2022Namrata Sajankumar BajajPromoterBuy5.0K₹17.4L347.5616.16L → 16.21L5.87%+0.02 pp7(2)told 31 Mar 2022

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 22 Jul 2026

CSV
12 of 110 deals
By year
DateDealClientQuantityPriceValue
22 Jul 2026Sell · bulkWESTSTONE MANAGEMENT CONSULTANCY PRIVATE LIMITED2.00L332.91₹6.7Cr
29 Jun 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED7.24L347.17₹25.1Cr
29 Jun 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED7.24L346.96₹25.1Cr
29 Jun 2026Buy · bulkQE SECURITIES LLP5.28L347.89₹18.4Cr
29 Jun 2026Sell · bulkQE SECURITIES LLP5.27L345.48₹18.2Cr
29 Jun 2026Buy · bulkJUNOMONETA FINSOL PRIVATE LIMITED4.81L347.67₹16.7Cr
29 Jun 2026Sell · bulkJUNOMONETA FINSOL PRIVATE LIMITED4.77L347.91₹16.6Cr
29 Jun 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED4.53L347.59₹15.7Cr
29 Jun 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED4.53L347.27₹15.7Cr
29 Jun 2026Sell · bulkBLITZQUANT RESEARCH LLP2.98L347.05₹10.3Cr
29 Jun 2026Buy · bulkBLITZQUANT RESEARCH LLP2.98L346.86₹10.3Cr
29 Jun 2026Sell · bulkGRT STRATEGIC VENTURES LLP2.15L347.33₹7.5Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to BAJAJHCARE.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations108.6133.9132.2133.1122.8154.5148.8147.9161.2153.1165.6175.9
Other income0.86.50.92.62.413.60.91.71.63.00.80.9
Total income109.4140.4133.1135.7125.2168.0149.7149.6162.9156.0166.4176.8
Total expenses103.0131.2122.9123.2113.5156.3135.2133.6143.6143.6150.0158.3
└ Finance costs6.76.08.47.95.56.15.25.65.95.66.16.0
└ Depreciation7.47.36.76.86.97.55.67.17.27.67.07.6
Profit before tax6.3(35.1)10.212.411.711.714.516.019.2(20.8)16.518.5
Tax expense0.8(3.1)2.24.1(3.3)0.12.43.53.1(1.4)2.64.1
Net profit(2.2)(29.9)7.19.511.711.211.811.115.7(22.9)13.714.1
EPS-0.80-10.842.593.363.653.543.743.534.96-7.164.074.19
Net margin-2.02%-22.35%5.39%7.11%9.55%7.24%7.95%7.51%9.72%-14.93%8.27%8.01%
PBT margin5.83%-26.25%7.70%9.35%9.49%7.59%9.76%10.79%11.94%-13.60%9.94%10.50%
Tax rate12.67%—21.19%32.97%-28.43%1.10%16.19%22.01%16.34%—15.59%22.17%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 17 Oct 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets901.5837.9765.1803.9833.0838.9923.2981.1
Current assets509.7476.6405.7456.7485.4472.9569.1572.3
└ Cash & equivalents17.75.52.221.52.612.037.213.5
└ Other bank balances0.04.80.81.41.82.00.80.7
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables227.4219.9180.2216.9251.7231.9233.9251.6
└ Inventories208.8202.8144.0142.4161.9156.3216.0236.5
Total equity367.7316.1278.4445.8466.2486.4533.0557.2
└ Attributable to owners367.7316.1278.4445.8466.2486.4533.0557.2
└ Share capital13.813.813.815.815.815.816.816.8
Borrowings414.3356.1332.1205.1222.6221.2233.5267.5
└ Current320.7298.6267.0173.8158.0164.7185.9197.1
└ Non-current93.757.565.031.364.756.547.670.4
Trade payables84.881.289.490.595.582.8115.3111.5
Current liabilities436.1412.6375.7288.0272.3269.8319.6324.4
Total liabilities533.8521.8486.8358.1366.9352.5390.2424.0
Net debt396.6345.8329.1182.2218.2207.2195.5253.3
Debt / equity1.131.131.190.460.480.450.440.48
Current ratio1.171.161.081.591.781.751.781.76

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow(22.3)41.692.325.721.650.258.115.7
└ Capex(93.6)(22.5)(30.3)(5.7)(11.5)(11.0)(43.3)(61.0)
Free cash flow(115.9)19.162.020.010.139.214.7(45.3)
Investing cash flow(93.4)(22.4)(11.2)(5.8)(14.8)(19.8)(47.8)(53.2)
Financing cash flow131.5(31.4)(96.6)(0.6)(6.4)(21.0)24.313.8
└ Dividends paid(4.1)0.0(2.8)0.0(2.8)0.0(3.2)(5.0)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash15.7(12.2)(15.5)19.30.49.434.6(23.8)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

BAJAJHCARE at a glance

  • BAJAJHCARE closed at ₹320.15 on 20 Nov 2026, +0.52% on the day, -28.4% over one year, 30.1% below its 52-week high of ₹458.
  • Delivery was 52.8% of traded quantity on 20 Nov 2026, the 70th percentile of its own 1,235 sessions with a reading (20-session average 50.2%, 1-year average 43.3%).
  • Market capitalisation is ₹1,078 crore at a trailing P/E of 52.3 (trailing EPS ₹6.12).
  • Q2 FY27 results (standalone, filed 17 Oct 2026): revenue ₹176 crore (+18.9% year on year), net profit ₹14 crore (+26.9%); the price moved -0.8% on the first session after.
  • Promoters held 58.59% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 16 Jan 2027 and 12 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE411U01027
SeriesEQ
Listed25 Nov 2021
NSE market cap · 17 Nov 2026₹1,083 Cr
Free-float market cap (NSE)₹411 Cr
Shares outstanding (NSE)3.37Cr
History from25 Nov 2021
Sessions1,238

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.